# Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia

> **NCT01318226** · PHASE2 · COMPLETED · sponsor: **Aestus Therapeutics** · enrollment: 61 (actual)

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** ATx08-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01318226
- **Lead sponsor:** Aestus Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2011-08-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01318226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01318226, "Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01318226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*